The cecal contents of guinea pigs with clindamycin-associated colitis contained a heat-labile toxin. This toxin was lethal for guinea pigs and mice, produced vascular permeability in the skin of rabbits, and was cytotoxic in tissue culture. The lethality in mice, vascular permeability in rabbit skin, and cytotowicity in tissue culture monolayers were neutralized by Clostridium sordellii antitqxin.
Antibiotic-associated colitis in guinea pigs has been associated with a variety of antimicrobial agents (10, 11, 13, 14, 15) . Several investigators have implicated Clostridium difficile toxins in clindamycin-associated colitis in humans (17, 22) and hamsters (7, 23) . More recently, Clostridium perfringens type E toxin has been implicated in clindamycin-associated colitis in rabbits (16) , and Clostridium histolyticum toxin has been similarly implicated in guinea pigs (15) . The purpose of this study was to investigate the association of a bacterial toxin in the pathogenesis of clindamycin-associated colitis in guinea pigs. Knoop (15) demonstrated a toxin in the feces of clindamycin-treated guinea pigs which was lethal for guinea pigs. C. histolyticum antisera neutralized the cytotoxic effect in the Y-1 adrenal cell assay, but neutralization of the toxin's lethal effect was not tested. In the present study, a lethal heat-labile toxin was demonstrated in the cecal contents of guinea pigs with clindamycin-associated colitis. The lethality in mice and vascular permeability in the rabbit skin assay were neutralized by C. sordellii antitoxin.
MATERIALS Cecal filtrate samples of clindamycin-treated animals (CL-FIL) were stored at -70'C and thawed just before individual experiments. Cecal contents from salinetreated animals (CON-FIL) were processed the same as those of clindamycin-treated animals. Bacteriological sterility of the filtrates was confirmed by: (i) inoculating 1 ml of filtrate from each sample into 10 ml of thioglycollate broth and incubating aerobically at 370C and (ii) culturing a sample of filtrate on blood agar under aerobic and anaerobic conditions. All samples were checked daily for 2 weeks for evidence of bacterial growth. At the end of 2 weeks, a sample from each tube was cultured on blood agar under both aerobic and anaerobic conditions. Protein concentrations were determined by the method of Lowry et al. (19) . Lethal Heat sensitivity assay. Samples tested for heat sensitivity were incubated at 60'C for 30 min and cooled to room temperature before intradermal or intraperitoneal injection of test animals. Control samples were incubated at room temperature.
Toxin neutralization. Toxin neutralization tests were performed by testing the ability of C. sordeliii (lot 4761G; 100 U/ml), C. histolyticum (lot 3647G; 800 U/ml), C. novyi type A (lot 5451G; 250 U/ml), C. septicum (lot 7035G-100; 85 U/ml), C. perfringens type A (lot 3973G; 115 U/ml) (all from American Cynamid Co., Lederle Laboratories Div., Pearl River, N.J.), and C. perfringens type E (lot K6292; Burroughs Wellcome Research Laboratories, Bechenham, England) antitoxins to neutralize CL-FIL lethality in mice, vascular permeability in the rabbit skin assay, and cytotoxicity in WI-38 cell cultures. Three CL-FIL 24-h mouse LD50 units were incubated with 0.5-ml twofold serial dilutions of each of the specific antitoxins in a final volume of 1 ml for 1 h at 250C before intraperitoneal inoculation.
A 100-pd sample of a 1:6 dilution of CL-FIL was incubated for 1 h at 250C with an equal volume of twofold serial dilutions of each of the six specific antitoxins before intradermal injections. A 100-,il dose of the toxin-antitoxin mixture was injected intradermally; each dilution was tested eight times in a minimum of four rabbits. CL-FIL was also incubated with mycoplasma-free horse serum (control no. E051412) (GIBCO Laboratories, Grand Island, N.Y.) or 0.1 M phosphate-buffered saline (pH 7.2) for 1 h at 25 or 37°C before testing in all three bioassays.
Cytotoxic-positive CL-FIL was retested in the WI-38 cell culture assay with an equal volume of a 1:10 dilution of monovalent clostridial antitoxin or horse serum by John G. Bartlett (4) . Cecal filtrates from control animals and the six antitoxins were also tested for cytotoxicity.
RESULTS
Death after subcutaneous injection of clindamycin. Thirteen of the 18 guinea pigs died during the 14-day observation period after subcutaneous administration of clindamycin. All 13 deaths occurred between days 3 and 9 after clindamycin administration. Grossly, the animals had fluid-filled distended ceca with varying degrees of hyperemia. The ceca of eight animals autopsied immediately upon death were examined microscopically. These ceca showed capillary congestion, polymorphonuclear infiltration of the lamina propria and submucosa, and occasional focal erosion of the mucosal epithelium.
Toxicity of CL-FIL for guinea pigs and mice. Six guinea pigs died within 24 h of intraperitoneal injection of 1 ml of CL-FIL. None of the six control guinea pigs died within the 7-day observation period after injection of 1 Neutralization of CL-FIL activity by clostridial antitoxins. C. sordellii antitoxin diluted 1:64 was the lowest concentration that protected mice for 24 h, whereas 7-day protection was achieved only with dilutions of 1:16 or lower. C. histolyticum, C. novyi, C. septicum, and C. perfringens type A or type E antitoxins and control horse serum did not protect mice from the lethal effects of CL-FIL (Table 1) .
C. sordellii antitoxin prevented the blueing effect of induration at 1:64 dilution or lower. Blueing and induration produced by CL-FIL were not prevented by incubation with normal horse serum or antisera of C. histolyticum, C. novyi, C. septicum, and C. perfringens type A or E (Table 2) .
C. sordellii antitoxin neutralized the cytotoxic effect of CL-FIL on tissue culture monolayers of WI-38 cells. Neither C. histolyticum, C. novyi, C. septicum, or C. perfringens type A or type E antitoxin, nor control horse serum, neutralized the cytotoxic effect of CL-FIL. a One-tenth milliliter of the indicated clostridial dilution was incubated with an equal volume of a 1:6 dilution of CL-FIL; 0.1 ml of this incubation mixture, with one blueing dose, was injected intradermally. -, 0-mm diameter of blueing; +, >6-mm average diameter of blueing.
injected intraperitoneally. These filtrates produced edema, hemorrhage, and increased vascular permeability in rabbit skin. They also produced cytotoxic changes in cell cultures. These toxic preparations of the cecal filtrates were neutralized by in vitro incubation with C. sordellii antitoxin but not with other clostridial antitoxins. The lethal effect of the guinea pig CL-FIL, its vascular permeability effect in rabbit skin, its cytotoxicity in cell cultures, and its heat lability resemble the properties of C. sordellii toxins (1, 2) . The morphological alterations in the ceca of guinea pigs that died after subcutaneous administration of clindamycin were similar to those of hamsters (6) and guinea pigs (15) with clindamycin-associated colitis.
Toxigenic C. difficile is presumed to be the cause of clindamycin-associated colitis in hamsters (7, 23) and humans (8, 17) . The toxins derived from clindamycin-treated hamsters (23) and humans (17, 18) or from culture filtrates of C. difficile are reported to be neutralized by C. sordelhii antitoxins (4, 7, 23) . These studies suggest that C. sordellii and C. difficile produce a common toxin or share a toxic component, or that C. sordellii antitoxin available for these studies was not a monovalent antitoxin. Recent studies employing partially purified C. difficile and C. sordellii toxins demonstrated no crossreactivity with antisera specific for these toxins (3). The cross-reactivity with C. difficile toxin and U.S. Standard C. sordellii antitoxin has been questioned and attributed to possible impurity of the original strain used in preparation of the antitoxin (3, 8) . Knoop (15) has demonstrated the presence of Until now, only one toxigenic Clostridium sp. has been implicated in any one animal species with clindamycin colitis, but the possibility that multiple toxigenic clostridia occur within one animal species may also account for the difference in our data and Knoop's. Rifkin et al. (21) have isolated both C. difficile and C. sordelhii from hamsters with clindamycin colitis; however, the C. sordellii isolates were not toxigenic. The association of multiple toxigenic clostridia within an animal or animal population may account for the variation observed in the passive immunity (1, 5) and antimicrobial therapy studies (6, 10, 11, 14) employed in antibiotic-associated colitis. Antibiotic-associated colitis in humans and animals may not be as simplistic as initially thought.
The role of Clostridium spp. other than C. difficile in the various animal models and in humans needs to be pursued. 
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